The antibacterial activity of BK-218 was similar to that of cefamandole when it was tested against several laboratory strains. The inhibiting effect of BK-218 was greater than that of cephalexin and cefoxitin on penicillin-binding proteins of Escherichia col HB101. This result was in close correlation with the relative inhibition of radiolabeled glucosamine incorporation (greatest with BK-218) and with the lytic effect (most intensive with BK-218). BK-218 proved to be a good inhibitor for all five of the ,-lactamases that were investigated, although two enzymes (Enterobacter cloacae P99 and Pseudomonas aeruginosa Cilote) hydrolyzed it to some extent.
Cephalexin (4), cefadroxil (7) , cefaclor (4, 21) , cefroxadine (34) , and cefatrizine (22) have been widely used for clinical purposes as oral cephalosporins, but their usage is limited because they have relatively narrow spectra against various strains of pathogenic bacteria and are hydrolyzed by 1- lactamases. BK-218, 5-thia-1-azabicyclo [ Fig. 1.) , is a new oral cephalosporin.
It is well-known that beta-lactam antibiotics first bind to their targets, the so-called penicillin-binding proteins (PBPs). The inhibition of these enzymes suspends peptidoglycan synthesis, and as a consequence the autolytic enzymes are triggered with a mechanism whose details are not completely understood (16) .
The purpose of this study was to report the results of preliminary investigations concerning the in vitro activity of BK-218 against a limited number of gram-positive and gramnegative bacteria. The MICs of BK-218 were compared with those of other parenteral (cefuroxime, cefamandole, and cefoxitin) and oral (cephalexin) antibiotics.
The in vitro effect on the targets was measured by (i) affinity to PBPs, (ii) incorporation of labeled glucosamine into the cell wall of Escherichia coli, and (iii) release of labeled glucosamine-containing fragments from prelabeled cell wall of E. coli to assess the lysis capability of BK-218.
The susceptibility of BK-218 to hydrolysis by 1-lactamases was also investigated. MATERIALS SDS-polyacrylamide gel electrophoresis and fluorography. SDS-polyacrylamide gel electrophoresis was done as described by Laemmli and Favre (19) with acrylamide contents of 4 and 10% (wt/vol of each) in the stacking and running gels, respectively. After separation of the proteins at a constant 360 V, the gels were fixed in a solution containing 5% (vol/vol) methanol and 7.5% (vol/vol) acetic acid. Gels were placed in dimethyl sulfoxide to remove water, followed by 2 h of incubation in a 20% (wt/vol) solution of 2,5-diphenyloxazole in dimethyl sulfoxide. Following rehydration, gels were dried and exposed to Medifort RP X-ray film for 7 to 10 days at -70°C (5). The band intensities were measured by densitometry (Kipp and Zonen densitometer DD2). The half-saturation cephalosporin concentration (I50 value) for PBPs was calculated from the optical density of a cephalosporin-inhibited PBP band and from the optical density of the control band which was not treated with betalactam antibiotics.
Incorporation of labeled glucosamine into cell wall of E. coli HB101. A 500-,ul sample of an exponentially growing culture (optical density, 0.5 at 550 nm) was pretreated with 3.8 x 10-5 M cephalosporin for 10 min (at 100 rpm and 37°C) in a rotatory shaker (New Brunswick Scientific Co., Inc., New Brunswick, N.J.).
After the addition of 9 kBq of N-acetyl-D-[1-3H]glucosamine (specific activity, 105 GBq/mmol; Amersham International plc, Amersham, United Kingdom), the culture was incubated for 15 min, the radioactivity was chased for 10 min with cold glucosamine (final concentration, 10 mM), and counts and disintegrations per minute retained in boiling SDS-precipitable material were measured (filtered on Millipore membrane; pore size, 0.45 ,um; Millipore Corp., Bedford, Mass.). The final concentration of SDS was 5%, and each precipitate was washed with 10 ml of the same SDS solution.
The radioactivity was measured with a scintillation counter (Isocap/300; Nuclear-Chicago Corp., Des Plaines,
Ill.).
Release of cell wall fragments from E. coli HB101. NAcetyl-D-[1-3H]glucosamine (55.5 kBq) (specific activity, 105 GBq/mmol) was added to 3 ml of an exponentially growing culture of E. coli at 37°C (optical density, 0.5). After 90 min of incubation at 37°C and 200 rpm in a rotatory shaker (New Brunswick Scientific), the culture was chased with cold glucosamine.
The cells were washed three times with fresh medium, centrifuged at 10,000 x g for 5 min, and suspended in a fresh culture medium containing 3.8 x 10-5 M antibiotic. The cultivation was continued under the same conditions as before. Samples were taken at different times, and the radioactivity of the supernatant (centrifugation at 10,000 x g for 5 min) was measured with the same scintillation counter as described above.
Determination of Km, Vmax, and Vrel values. The kinetic experiments were done in a final volume of 3 ml of incubation mixture at 37°C in 0.05 M phosphate buffer, pH 7 (23, 25, 33) . In the case of significant hydrolysis of some of the cephalosporins susceptible to certain 3-lactamases, evaluation of the kinetic parameters was made in the 0.5-to 5.0Km substrate concentration interval (33) .
Assessment of Ki values for enzymes. The inhibition studies
were done under conditions similar to those described above. The enzyme samples were preincubated for 5 min, and the reaction was started with nitrocefin (Oxoid) as the substrate in each mixture (Km values were 56 p.M for P99 [33] , 136 ,uM for TEM-1 [23] RESULTS BK-218 did not inhibit Bordetella bronchiseptica, AcineAntibacterial activity. To assess the antibacterial spectrum tobacter anitratus, Aeromonas hydrophila, P. aeruginosa, of BK-218, we compared its activities against typical laboor Xanthomonas maltophilia at 128 jig/ml. ratory strains with those of cefuroxime, cefamandole, cefAffinity for PBPs of E. faecalis ATCC 9790 and E. coli oxitin, and cephalexin (Table 1) .
HB101. The affinities for PBPs of BK-218, cefoxitin, and BK-218 had excellent activity against gram-positive baccephalexin were examined by measuring the competition of teria except methicillin-resistant S. aureus and E. faecalis.
the investigated beta-lactam antibiotics with '4C-labeled The MICs were lower than MICs of other beta-lactams. The penicillin G. Table 2 shows the results of the competition MICs of BK-218 ranged from 0.12 to 8 ,ug/ml against most quantitatively.
strains of the family Enterobacteriaceae, except cephalo-BK-218, cefoxitin, and cephalexin had very high affinities sporinase-producing E. cloacae, Serratia marcescens, and for PBP 2 of E. faecalis (Table 2) , but cefoxitin was a better Morganella morganii strains.
inhibitor of PBP 1 than was BK-218. Cephalexin had mod- erate affinity toward all the other PBPs of E. faecalis, including PBP 3.
As shown in Table 2 , BK-218 had higher or at least equal affinity for the lethal targets (PBP 1, PBP 2, and PBP 3) of E. coli (13) than cefoxitin and had significantly higher affinity than cephalexin.
Incorporation of labeled glucosamine. An exponentially growing culture of E. coli HB101 was pretreated with 3.8 x 10' M cephalosporin. After 10 min of pretreatment, tritiated N-acetyl glucosamine (which incorporates predominantly into the cell wall; 12, 24) was added to the culture. Glucosamine incorporation was about 50% of the control (7,600 dpm) when BK-218 was added (3,600 dpm). Cefoxitin had less of an inhibitory effect (5,600 dpm) and cephalexin had essentially no effect (7,400 dpm) on the incorporation.
Release of cell wall fragments. The cell wall of E. coli HB101 was labeled with [3H]glucosamine, after which the release of the radioactivity was measured under the influence of different cephalosporins. The control culture, which was not treated with any antibiotic, showed a low but continuous release of radioactivity because of the turnover of cell wall material (Fig. 2) . The release of radioactivity was extensive in the culture treated with BK-218, while the effect of cefoxitin on release was moderate. Cephalexin did not cause significant release above that seen in untreated controls.
P-Lactamase stability of BK-218. ,B-Lactamase stability of BK-218 was investigated with five beta-lactam-hydrolyzing enzymes. Two of the enzymes were of gram-positive-bacterial origin: S. aureus PC1 and B. cereus 569/H/9 P-lactamase I. The gram-negative strains and their enzymes were as follows: E. cloacae P99, P. aeruginosa Cilote CARB-3 type, and E. coli RTEM+ TEM-1. We found that only the P99 and Cilote enzymes were able to hydrolyze BK-218 to a significant extent (Vmax values, 130 and 100 ,umol/min, respectively), while BK-218 did not prove to be a substrate for the rest of the investigated enzymes (Vmax values, '10 nmol/min). To characterize these results, we correlated the data with the P-lactamase stabilities of cefuroxime, cefoxitin, and cephalexin. Of these beta-lactams, only cephalexin was hydrolyzed by TEM-1 l (120 ,umol/min), while its breakdown with the P99 enzyme was small (40 nmol/min). The compounds were not hydrolyzed by any other enzyme. Inhibition kinetic studies (Table 3) showed that BK-218 was the best inhibitor of PC1 and weakest against TEM-1. MICs of beta-lactam antibiotics alone do not elucidate characteristics such as binding to target enzymes, penetration of the outer membrane, effect of cell wall synthesis, and lysis. For example, the permeability barrier may prevent the beta-lactam from reaching the target enzyme even in the case of a compound which has high affinity for PBPs. The investigation of the latter by the use of isolated cytoplasmic membranes containing PBPs may help to clear up the problem. On the basis of these results, however, the rate of lysis and cell wall inhibition cannot be predicted, since several PBPs take part in the process. The inhibition of cell wall synthesis and the lysis of the cell wall can be measured by the use of labeled glucosamine which can incorporate into the peptidoglycan.
In an investigation of the inhibition of PBPs of E. faecalis by BK-218, cefoxitin, and cephalexin, it was shown that BK-218 had lower affinity for PBP 1 than cefoxitin and higher affinity for PBP 3 than cefoxitin and cephalexin. PBP 3 is considered to be the major lethal target of E. faecalis (13) . BK-218 was an excellent inhibitor of PBP 6, which is known to be a nonlethal target. As seen with carboxypeptidases of different strains, inactivation does not influence the MICs. BK-218 was very effective against numerous gram-negative strains.
The effect of BK-218 on E. coli HB101 was investigated in detail. When the PBP-inhibiting effects of BK-218, cephalexin, and cefoxitin were compared, BK-218 proved to be the best inhibitor of the lethal targets of E. coli (28) . The MIC (0.25 ,ug/ml) of BK-218 against E. coli HB101 is not significantly higher than the 150S for PBP 1 and PBP 2. This suggests that BK-218 may penetrate the outer membrane of E. coli well.
The experiments on cell wall synthesis and lysis were done with concentrations of BK-218, cefoxitin, and cephal-exin that were two magnitudes higher than the MIC of BK-218. This proved to be the optimal concentration (data obtained with other concentrations are not given here) for demonstrating the differences among the three investigated cephalosporins. This concentration promoted the quick and thus easily measurable inhibition of cell wall synthesis and lysis of labeled cell wall. The difference between the effects of BK-218 and cefoxitin on cell wall synthesis and lysis could not be predicted from the 150 values (Table 3) because it is not known how much the three lethal targets (PBP 1, PBP 2, and PBP 3) are involved quantitatively in these processes.
We believe that the results given above on cell wall synthesis and lysis demonstrate more precisely the effect of beta-lactams on bacteria than do mere MICs and MBCs.
BK-218 proved to be the best inhibitor of the S. aureus PC1 enzyme. Cefuroxime and cephalexin did not inhibit this enzyme significantly. Our results showed BK-218 to be a much better inhibitor of P-lactamase I from B. cereus 569/H/9 than the standard cephalosporins used in these experiments. Reference Ki data are available mainly for methicillin (14) and isoxazolyl penicillins (2) but not for cephalosporins, with the exception of cephalosporin C (1). Therefore, our values can be informative for research purposes.
As to the Ki values of BK-218 compared with those of the standards for enzymes of gram-negative bacteria, one may observe a diverse picture. P99 was less inhibited by BK-218 than by cefuroxime and was inhibited to about the same extent as by cefoxitin and cephalexin. It is known that moxalactam is a good inhibitor of this enzyme (Ki, 62 nM; 8).
The P. aeruginosa Cilote ,-lactamase was approximately equally inhibited by BK-218 and cefoxitin, but cefuroxime and cephalexin proved to be poor inhibitors. Comparative data from references show that cephaloridine (29) and cephalothin (3, 18) are not stable against P-lactamases of different P. aeruginosa strains and are also poor inhibitors. However, cefotaxime and ceftriaxone (31) are stable inhibitors for many enzymes of these strains. E. coli has not been extensively investigated, but the available Ki values are consistent with our findings (26) . Ki values of cefuroxime (650 ,uM) and moxalactam (810 ,uM) (8) were found to be in the same range as that of BK-218. In sum, we regard BK-218 as a promising candidate for gram-negative-bacterial screening despite the fact that two investigated enzymes hydrolyzed it to some extent.
